Cellebrite Reports Strong Q3 2025 Financial Results with 18% Revenue Growth

An announcement from Cellebrite DI ( (CLBT) ) is now available.

On November 12, 2025, Cellebrite announced its third-quarter financial results, highlighting a revenue increase of 18% to $126 million and an ARR growth of 19% to $439.8 million. The company reported a net income of $20.2 million, with a non-GAAP net income of $36.9 million and an adjusted EBITDA of $37.7 million. Cellebrite’s performance reflects strong demand, particularly in the U.S. Federal sector, and the company is optimistic about future growth, driven by product development and strategic acquisitions. Recent innovations include the Autumn 2025 Release, which introduced new capabilities to their Digital Investigation Platform, and the appointment of Holly Windham as General Counsel and Chief Compliance Officer.

The most recent analyst rating on (CLBT) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Cellebrite DI stock, see the CLBT Stock Forecast page.

Spark’s Take on CLBT Stock

According to Spark, TipRanks’ AI Analyst, CLBT is a Neutral.

Cellebrite DI’s overall stock score is primarily influenced by its strong earnings call performance, highlighting growth and strategic initiatives. However, financial challenges such as negative profitability and bearish technical indicators significantly weigh down the score. The negative valuation metrics further contribute to a lower overall score.

To see Spark’s full report on CLBT stock, click here.

More about Cellebrite DI

Cellebrite DI Ltd. is a global leader in digital investigative solutions, serving both public and private sectors. The company specializes in digital forensics and intelligence, focusing on enhancing public safety through its advanced technology solutions.

Average Trading Volume: 1,783,826

Technical Sentiment Signal: Sell

Current Market Cap: $3.74B

For an in-depth examination of CLBT stock, go to TipRanks’ Overview page.